NDS-446
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NDS-446, covering 2016-06-21 to 2025-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks [Phase 4]